WO2004006887A3 - Compositions et methodes pour le traitement de troubles cutanes - Google Patents

Compositions et methodes pour le traitement de troubles cutanes Download PDF

Info

Publication number
WO2004006887A3
WO2004006887A3 PCT/IL2003/000576 IL0300576W WO2004006887A3 WO 2004006887 A3 WO2004006887 A3 WO 2004006887A3 IL 0300576 W IL0300576 W IL 0300576W WO 2004006887 A3 WO2004006887 A3 WO 2004006887A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
treatment
composition
skin disorders
analogs
Prior art date
Application number
PCT/IL2003/000576
Other languages
English (en)
Other versions
WO2004006887A2 (fr
Inventor
Avikam Harel
Olga Bloch
Original Assignee
Avikam Harel
Olga Bloch
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/192,842 external-priority patent/US20030032617A1/en
Application filed by Avikam Harel, Olga Bloch filed Critical Avikam Harel
Priority to EP03764101A priority Critical patent/EP1539100A4/fr
Priority to AU2003242965A priority patent/AU2003242965B2/en
Priority to CA002492248A priority patent/CA2492248A1/fr
Publication of WO2004006887A2 publication Critical patent/WO2004006887A2/fr
Publication of WO2004006887A3 publication Critical patent/WO2004006887A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/673—Vitamin B group
    • A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La présente invention concerne des méthodes et des compositions destinées à être utilisées dans le traitement d'une pathologie proliférative bénine et/ou maligne. Lesdites méthodes consistent à administrer du nicotinamide ou ses analogues et/ou de la cADPR ou ses analogues, éventuellement en combinaison avec un analogue de la vitamine D3 ou avec un analogue de la vitamine A.
PCT/IL2003/000576 2002-07-11 2003-07-10 Compositions et methodes pour le traitement de troubles cutanes WO2004006887A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP03764101A EP1539100A4 (fr) 2002-07-11 2003-07-10 Compositions et methodes pour le traitement de troubles cutanes
AU2003242965A AU2003242965B2 (en) 2002-07-11 2003-07-10 Composition and methods for the treatment of skin disorders
CA002492248A CA2492248A1 (fr) 2002-07-11 2003-07-10 Compositions et methodes pour le traitement de troubles cutanes

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/192,842 2002-07-11
US10/192,842 US20030032617A1 (en) 2000-01-11 2002-07-11 Composition and methods for the treatment of skin disorders

Publications (2)

Publication Number Publication Date
WO2004006887A2 WO2004006887A2 (fr) 2004-01-22
WO2004006887A3 true WO2004006887A3 (fr) 2004-03-18

Family

ID=30114413

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IL2003/000576 WO2004006887A2 (fr) 2002-07-11 2003-07-10 Compositions et methodes pour le traitement de troubles cutanes

Country Status (4)

Country Link
EP (1) EP1539100A4 (fr)
AU (1) AU2003242965B2 (fr)
CA (1) CA2492248A1 (fr)
WO (1) WO2004006887A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006120681A2 (fr) 2005-05-10 2006-11-16 Dermipsor Ltd. Compositions et procedes de soin de la peau
US7977049B2 (en) * 2002-08-09 2011-07-12 President And Fellows Of Harvard College Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms
US8017634B2 (en) 2003-12-29 2011-09-13 President And Fellows Of Harvard College Compositions for treating obesity and insulin resistance disorders
US20050288310A1 (en) * 2004-06-04 2005-12-29 Chemgenex Pharmaceuticals, Inc. Methods of treating cellular proliferative disease using naphthalimide and PARP-1 inhibitors
NZ563270A (en) 2005-05-10 2010-11-26 Dermipsor Ltd Calcipotriol, polyethylene oxide topical compositions for the treatment of hyperproliferative epidermal diseases
US9877981B2 (en) 2012-10-09 2018-01-30 President And Fellows Of Harvard College NAD biosynthesis and precursors for the treatment and prevention of cancer and proliferation
CN108836965A (zh) 2018-08-07 2018-11-20 浙江大学 尼克酰胺组合物在制备治疗索拉非尼手足皮肤反应药物中的应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5430049A (en) * 1993-12-08 1995-07-04 Gaut; Zane N. Treating hyperproliferative disorders
US5431925A (en) * 1991-12-13 1995-07-11 Snow Brand Milk Products Co., Ltd. Nutritive composition for prevention and therapy of infection diseases caused by immunosuppression
US5831074A (en) * 1988-11-02 1998-11-03 Strumwasser; Felix Eucaryotic NAD cyclases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4067975A (en) * 1975-08-04 1978-01-10 Yu Ruey J Treatment of psoriasis with 6-aminonicotinamide and thionicotinamide
US4505896A (en) * 1979-04-19 1985-03-19 Elorac, Ltd. Method of treating acne vulgaris and composition
DE4335454A1 (de) * 1993-10-19 1995-04-20 Schleicher Peter Geriatrikum
USH2013H1 (en) * 1997-05-23 2002-02-05 The Procter & Gamble Company Skin care compositions
DE29916231U1 (de) * 1999-09-15 2000-02-17 Renner Jobst Multivitamin- und -mineralpräparat
IL133976A (en) * 2000-01-11 2006-09-05 Dermipsor Ltd Agents for the treatment of skin disorders

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5831074A (en) * 1988-11-02 1998-11-03 Strumwasser; Felix Eucaryotic NAD cyclases
US5431925A (en) * 1991-12-13 1995-07-11 Snow Brand Milk Products Co., Ltd. Nutritive composition for prevention and therapy of infection diseases caused by immunosuppression
US5430049A (en) * 1993-12-08 1995-07-04 Gaut; Zane N. Treating hyperproliferative disorders

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1539100A4 *

Also Published As

Publication number Publication date
AU2003242965A1 (en) 2004-02-02
EP1539100A4 (fr) 2006-01-18
CA2492248A1 (fr) 2004-01-22
EP1539100A2 (fr) 2005-06-15
AU2003242965B2 (en) 2009-02-05
WO2004006887A2 (fr) 2004-01-22

Similar Documents

Publication Publication Date Title
EP1259240B8 (fr) Agents de traitement des troubles cutanés, tel le nicotinamide et le cADPR
WO2005067546A3 (fr) Derives et analogues de pyrrolopyrimidine et utilisation de ceux-ci dans le traitement a la prevention de maladies
MXPA05008406A (es) Compuestos de amida tri(ciclo)-sustituida.
IL154888A (en) Aqueous Pharmaceutical Gel Preparation Containing At least One Vitamin D or One Vitamin D Analog At least One Corticosteroid
WO2006120681A3 (fr) Compositions et procedes de soin de la peau
WO2007149406A3 (fr) Polypeptides facteurs ix de la coagulation modifiés et leur utilisation thérapeutique
WO2005079143A3 (fr) Formulations topiques pour le traitement d'etats dermatologiques
TW200507830A (en) Bronchodilating β -agonist compositions and methods
IL162765A (en) Diazabicycle derivatives, processes for their preparation, pharmaceutical compositions comprising them and their medical use
WO2001062235A3 (fr) Composition comprenant la camptothecine et un derive de pyrimidine et destinee a etre utilisee dans le traitement du cancer
MXPA05012358A (es) Combinacion farmaceutica que comprende modafinilo y otra droga.
WO2006064228A3 (fr) Composes
IL187575A (en) Benzofuranyl derivatives ,pharmaceutical formulations comprising the same and use thereof in the preparation of medicaments for the treatment of 5-ht6-receptor related disorders
WO2004006887A3 (fr) Compositions et methodes pour le traitement de troubles cutanes
WO2002012198A3 (fr) Derives 4-pyrimidinamines, compositions pharmaceutiques et procedes associes
WO2006002846A3 (fr) Nouveaux analogues de nitrobenzylthioinosine
WO2005070903A3 (fr) Composes
WO2004030623A3 (fr) Preparations de radioprotection a l'oxyde d'azote et leurs methodes d'utilisation
AR035988A1 (es) Derivados de pirrolo-(3,4-b)quinoleina, su procedimiento de preparacion y su uso para la preparacion de medicamento
WO2004073627A3 (fr) Methode et compositions therapeutiques pour administration topique
HK1079981A1 (en) A pharmaceutical preparation comprising a abacavirand alovudine and use thereof
WO2001041750A3 (fr) Nouvelles combinaisons therapeutiques de (s)-2-(benzylamino-methyl)-2,3,8,9,-tetrahydro-7h-1,4-dioxino[2,3-e]indol-8-one et neuroleptiques destines au traitement ou a la prevention de troubles psychotiques
AU8028600A (en) Methods, pharmaceutical and therapeutic compositions for administering adenosine
AU2002241416A1 (en) Dermatological agent for the treatment of skin trauma, especially in burn conditions
AU2002331892A1 (en) Topical pharmaceutical composition to treat hyperpigmentation of the skin

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2492248

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2003764101

Country of ref document: EP

Ref document number: 2003242965

Country of ref document: AU

WWP Wipo information: published in national office

Ref document number: 2003764101

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Ref document number: JP